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Abstract
Background: The Eastern Quebec Telepathology Network (EQTN) has been implemented in the province of Quebec 
(Canada) to support pathology and surgery practices in hospitals that are lack of pathologists, especially in rural and 
remote areas. This network includes 22 hospitals and serves a population of 1.7 million inhabitants spread over a vast 
territory. An evaluation of this network was conducted in order to identify and analyze the factors and issues associated 
with its implementation and deployment, as well as those related to its sustainability and expansion. 
Methods: Qualitative evaluative research based on a case study using: (1) historical analysis of the project documentation 
(newsletters, minutes of meetings, articles, ministerial documents, etc); (2) participation in meetings of the committee 
in charge of telehealth programs and the project; and (3) interviews, focus groups, and discussions with different 
stakeholders, including decision-makers, clinical and administrative project managers, clinicians (pathologists and 
surgeons), and technologists. Data from all these sources were cross-checked and synthesized through an integrative 
and interpretative process.
Results: The evaluation revealed numerous socio-political, regulatory, organizational, governance, clinical, professional, 
economic, legal and technological challenges related to the emergence and implementation of the project. In addition 
to technical considerations, the development of this network was associated with major changes and transformations 
of production procedures, delivery and organization of services, clinical practices, working methods, and clinical-
administrative processes and cultures (professional/organizational). 
Conclusion: The EQTN reflects the complex, structuring, and innovative projects that organizations and health systems 
are required to implement today. Future works should be more sensitive to the complexity associated with the emergence 
of telehealth networks and no longer reduce them to technological considerations.
Keywords: Telepathology Network, Telehealth Implementation, Evaluation, Sustainability, Healthcare Services
Copyright: © 2018 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access article 
distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is 
properly cited.
Citation: Alami H, Fortin JP, Gagnon MP, Pollender H, Têtu B, Tanguay F. The challenges of a complex and innovative 
telehealth project: a qualitative evaluation of the Eastern Quebec Telepathology Network. Int J Health Policy Manag. 
2018;7(5):421–432.  doi:10.15171/ijhpm.2017.106
*Correspondence to:
Hassane Alami   
Email: 
hassane.alami.1@ulaval.ca
Article History:
Received: 8 May 2017
Accepted: 29 August 2017
ePublished: 13 September 2017
Original Article
Full list of authors’ affiliations is available at the end of the article.
http://ijhpm.com
Int J Health Policy Manag 2018, 7(5), 421–432 doi 10.15171/ijhpm.2017.106
Implications for policy makers
• Telehealth is primarily a health system transformation challenge: the importance of a vision and strategy to improve the organization, 
coordination, financing and integration of health care and services using technology as a lever.
• Political will, organizational, clinical, administrative and technological leadership are central to ongoing innovation: complementarity and 
synergy between the stakeholders and the different health system governance levels in a co-construction and co-evolution approaches adapted 
to project various stages and sustainability.
• Telehealth involves changes in cultures, models of production and delivery of services, communication modes, practices and uses: the 
importance of managing change in a collaborative, participatory and inclusive approach of all actors (political, professional and organizational).
• Technology should be thought from an open-ended perspective: needs and uses are what gives value to the technology (eg, end users may find 
and adapt other applications not originally foreseen).
• Developmental-accompanying evaluation is essential to better understand the complexity and dynamics of IT projects. It makes it possible to 
share knowledge and support decision-making throughout the life of the project and beyond.
Implications for the public
This article allows the reader to have a global vision and overall understanding of the inherent issues of a complex telehealth network with a systemic 
dimension. Indeed, it sheds light on certain conditions that must be met and challenges that need to be addressed so that populations and the 
healthcare system can benefit from the potential of telehealth in improving access, continuity and quality of health care and services.
Key Messages 
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Background
Telehealth has the potential to improve access to care and the 
continuity of health services, especially for rural and remote 
areas, commonly called “medical deserts.”1 Because of its 
geographic and demographic situation and the drive of some 
leaders, the eastern part of the province of Quebec (Canada) 
has been historically innovative in the field of telehealth. This 
is the context in which the Eastern Quebec Telepathology 
Network (EQTN), one of the largest in the world in terms of 
the number of participating organizations and jurisdictions,2,3 
emerged.
Telepathology is a specialized field of telehealth. In short, 
telepathology is “the electronic transmission of pathological 
images, usually derived from microscopes, from one location 
to another, for the purpose of interpretation and diagnosis.”4 
It involves the practice of anatomopathology (commonly 
called “pathology”) at a distance. Telepathology can be used 
to establish a histopathological diagnosis, obtain a second 
medical opinion, or provide distance training by means 
of information and communications technologies (ICTs).4-7 
Telepathology allows a number of specialists (eg, pathologists 
and surgeons) and organizations (service recipients/requester 
and service providers/respondents) to network, by facilitating 
an exchange of clinical-administrative data and images in 
digital format, and sharing expertise. Telepathology can 
help improve access, quality, continuity, and efficiency of 
pathology services, particularly in rural and remote areas.8-13 
However, telepathology, like any innovative and structuring 
telehealth project, is accompanied by major changes and 
transformations inherent to the growing importance of ICTs 
in health systems reform and reorganization strategies.
This article describes the results of the EQTN evaluation and 
aims to identify and understand factors that have influenced 
the implementation, operation and results of this complex 
and innovative project. We present an analysis of the socio-
political, regulatory, organizational, governance, clinical, 
professional, economic, legal and technological dimensions 
that conditioned and oriented its planning, emergence, 
development, and implementation, as well as the conditions 
for its success, sustainability, deployment and expansion.
The Quebec Health System
In Canada, the organization and management of health 
policies are under provincial jurisdiction. The Federal 
Government contributes to the funding of provincial health 
systems through federal transfers that are conditioned by the 
respect of certain conditions.14 In Quebec, the health system 
is close to the Beveridgian model: mainly tax-funded, public, 
universal and almost free from the point of view of service 
users.15
With respect to governance, two main levels are present: (1) 
the Ministry of Health and Social Services (MHSS), which 
ensures close coordination and regulation by setting priorities, 
objectives and allocation of resources; and (2) the Institutions 
that deliver services. They include 22 Integrated Health and 
Social Services Centers (IHSSC) that result from a larger 
merging process to integrate, on a territorial basis, all the 
different functions and institutions related to health and social 
services, including hospitals and primary care services. Nine 
of them also include a university mission related to research, 
teaching and evaluation. They are designed as IUHSSS (U = 
university). IHSSC/IUHSSS provide the majority of public 
primary care and social services. The Institutions also include 
four university hospitals (UH) that deliver for the province 
specialized and subspecialized services and two specialized 
University Institute for Cardiology. They have a supraregional 
mission that requires them to cover several health regions. 
The four UH have always been central for the development 
of telehealth in Quebec. IHSSC/IUHSSS and hospitals are 
funded mainly in the form of overall budgets, based primarily 
on past expenditures, although activity-based funding is 
being generalized. 
Quebec has also created Integrated University Health 
Networks (IUHN), attached to the four faculties of medicine 
in the province. Their role is to foster complementarity, 
cooperation and integration of healthcare organizations with 
a university mission and the universities to which they are 
affiliated. Their role has been associated on a territorial basis. 
They have been given a special active role to foster telehealth 
development and implementation. 
Finally, there are also medical clinics and family medicine 
groups that primarily provide general medical services and 
may, in some cases, provide more specialized services. For 
the vast majority of their primary care or hospital services, 
physicians are mainly paid by activity and are bound by 
service agreements with the organizations where they work.
The Eastern Quebec Telepathology Network 
In 2004, the Quebec MHSS asked each of the four IUHN of 
the province to prioritize two telehealth projects. The IUHN-
Laval University (IUHN-LU) has opted for telepathology 
(for more technical and clinical information about this 
telepathology project see Têtu et al17 and Perron et al18). This 
choice resulted from the fact that the supply of pathology 
services has become a problematic issue in Quebec due to the 
province’s vast size and the uneven geographical distribution 
of the population. This situation is explained by the following: 
(1) a lack of staffing and difficulties in recruiting and retaining 
pathologists in remote areas; (2) difficult working conditions 
for pathologists when it comes to ensuring continuous 
services, due to the lack of replacement staff during holidays 
and difficult travel in winter; and (3) an over-specialization 
in pathology which, because of the risk of under-utilization 
of pathologists’ cutting edge expertise, makes it difficult to 
practice in small communities. This situation is also impacting 
the recruitment and retention of surgeons and other clinicians 
requiring pathology services in hospitals where there are no 
pathologists. 
According to MHSS figures, the IUHN-LU (1.7 million 
inhabitants for a territory of 410 000 km2) numbered 59 
pathologists in 2017. This represents a shortfall of at least five 
pathologists when it comes to providing coverage of all service 
requests, so leading to important waiting times that can affect 
quality of patient care.19 This situation has remained relatively 
stable for several years. Among IUHN-LU pathologists, some 
59,3% (35/59) are located in the capital (Quebec City) region. 
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The others (24/59) are distributed unevenly across a vast 
territory and their long-term retention is uncertain, especially 
given the age of most practicing pathologists. 
Initiated in 2006, the EQTN was jointly funded by the MHSS 
and Canada Health Infoway (CHI) in early 2008 with a 
non-recurring budget of slightly more than CA$6.2 million. 
This funding covered mainly technological devices. In 2011, 
the first clinical uses were initiated. The EQTN currently 
has 22 participating locations, including the University 
Hospital of Quebec-Laval University (UHQ-LU), which 
has a supraregional mission with a “safety net” role, which 
results in coverage of specific requests for services from other 
participating regions (Figure 1).
Unlike several similar projects, where the tertiary center 
is responsible for answering all requests for services from 
remote areas (eg, University Health Network Telepathology 
in Ontario21), this project has opted for a strategy based on 
inter-organizational and interregional collaboration. Indeed, 
it networks, both vertically and horizontally, organizations 
from the same region as well as those from different regions. 
The other strategy consists of targeting and being limited to 
services responding to urgent needs of an extemporaneous 
and a second opinion nature, especially in oncology. This 
strategy was seen as beneficial for the population and is 
sensitive to the issue of cancer and adapted to the payment 
conditions of the funders.
The EQTN project was designed to implement a clinical 
telepathology network as a viable and effective solution to 
providing support for IUHN-LU hospitals in order to avoid 
shortages in pathology services and to expand the range of 
services provided. 
Evaluation: Scope and Objectives
The specific EQTN evaluation project was initiated in 
2013. It was intended to provide information for decision-
making regarding project orientations and improvements 
to be implemented for its successful deployment within 
a perspective of sustainability and scaling-up across the 
province.
The main objectives of this evaluation were the following: (1) 
to study the functioning of the project in relation to the actors, 
issues, and strategies used; (2) to better understand the results 
and effects of use on access, continuity and quality of services 
and work, service organization, and practice transformation; 
(3) to explore socio-political, regulatory, organizational, 
governance, clinical, professional, economic, legal and 
technological factors influencing implementation, adoption 
and use, and ultimately the sustainability and dissemination 
of telepathology; and (4) to identify conditions that may be 
useful to ensure better integration and diffusion of telehealth 
in health systems.
Methods
Evaluative Approach
To take into account the characteristics of the project – 
innovative, complex, dynamic, and evolving – and decision-
makers’ need to monitor and integrate the lessons of the 
evaluation into their decision-making processes, we opted for 
a case study, particularly appropriate when the focus of study 
cannot be separated from its context.22,23
We adopted a utilization-focused evaluation approach24 
whose aim is the following: (1) descriptive and explanatory, to 
determine how, according to certain rules, stakeholders cope 
and deal with complex phenomena25; (2) comprehensive, eg, 
to take stock of all facts and issues related to the unfolding of 
the project26,27; (3) participatory and pluralistic, to include the 
perspectives of the various stakeholders, partners, and actors 
involved in the project24,28; (4) progressive (developmental) and 
formative, in order to ensure co-construction, field support, 
and translation of knowledge in action with all the actors, 
taking into account the different stages of the project29; and 
(5) summative, to assess the achievement as regards the initial 
objectives.
Conceptual Framework
To structure the approach, ensure its integration into the 
overall project, and complete the proposed evaluation plan, we 
used the Strategic framework for a useful and used evaluation 
(Figure 2).30 This framework makes it possible to take into 
account the characteristics and different stages of the project, 
the actors and stakeholders, the environment, the issues, as 
well as the different levels of intervention. It also facilitates the 
choice of methods and the evaluation and knowledge-sharing 
strategies to be adopted as appropriate given the innovative 
nature of the project.
Data Collection Activities
Data used for the evaluation included (1) a historical analysis, 
over a 10-year period, of all documentation related to the 
project (eg, newsletters, minutes of meetings, activity tracking 
and monitoring documents, protocols and guidelines, 
periodic presentations, use evaluation reports, articles, and 
documents from government and funding agencies), the goal 
of which was to reconstruct the sequence of key events and 
situate them in their context, while highlighting the critical 
decisions and the reasons they were made, as well as the 
role of the different actors in the evolution of the project; 
Figure 1. The Territory Covered by the EQTN, at a Given Time, 
With Examples of Interactions Between the Different Participating 
Organizations.20
Abbreviation: EQTN, Eastern Quebec Telepathology Network.
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(2) participant observation of meetings of the governance 
committee in charge of the project; and (3) interviews, 
meetings, discussions, and exchanges (formal and informal) 
with project stakeholders, including policy-makers, managers, 
clinical, technological, and administrative project officials, 
pathologists, surgeons, and technologists.
The people interviewed were identified primarily by the 
project team as well as by way of project documents and 
reports. Internet searches were also conducted to identify 
other key people in participating organizations. Participant 
selection was guided by the need to gather a diversity of 
perspectives from the different stakeholders involved in the 
project. 
Interviews were recorded and transcribed verbatim. 
Subsequently, verbatim, documents and observation notes 
were subjected to a qualitative thematic content analysis,31 
using a deductive-inductive approach based on the framework 
and new themes emerging from the data, with the help of 
NVivo-10 software.32 Analyses were carried out by HA and 
HP; a third person was able to intervene when there was a 
difference in perspective in the case of divergence (JPF). In 
order to increase our interpretation and analysis capacity, we 
cross-checked the results from the different sources described 
above, in line with the principle of data triangulation.33 Thus, 
we were able to formulate and re-evaluate our conclusions by 
regularly returning to the primary sources of data to detect 
possible variations and convergences/divergences.31,34 This 
approach made it possible to verify, qualify, and complete our 
findings and observations. Moreover, the proximity to the 
project of certain authors also made it possible to establish 
trust reports, which allowed for communication and contact 
with all actors. This element also forced us to adopt a reflexive 
approach throughout the evaluation, in particular by having a 
critical look at all the data collected.35
Given our evaluation mandate within a healthcare organization, 
we have applied the principles of the “Guidelines for Ethical 
Conduct” recommended by the Canadian Evaluation Society 
(integrity/honesty, accountability, confidentiality, respect, 
and responsibility for people’s welfare).36
Results 
We conducted 19 interviews (9 clinicians, 7 managers 
and decision-makers, and 3 technologists) and made 3 
observation site visits. We observed and participated to 4 
project team meetings (2 hours each), 2 biannual meetings 
involving participating locations (3 hours each), and 15 
meetings of the telehealth executive committee – including 
the MHSS representatives – where the telepathology project 
was on the agenda (2.5 hours each). We also had access to the 
project documentation (project planning, project operations 
manual, articles related to the project, use evaluation report, 
minutes of meetings, use tracking reports, project newsletter, 
telepathology clinical guidelines, international telepathology 
cooperation documents, pathology and surgery medical 
staffing plans, closing report of the project and ministry’s 
telehealth governance plan). 
The same information was often derived from interviews, 
meetings, documentation, or observation. In fact, we 
applied triangulation principles and merged these data into 
a coherent or integrative-interpretative synthesis. The results 
are structured according to the following criteria (from the 
evaluation framework): (1) use and effects; (2) clinical, 
professional and human aspects; (3) organizational aspects; 
(4) governance and strategic aspects; (5) technological aspects; 
(6) legal aspects; and (7) economic and financing aspects. 
Use and Effects 
Important evaluations were made by colleagues, mainly 
focused on the planned uses of telepathology, were conducted 
during the project.3,20,37,38
Our study added more information. Indeed, for the expected 
effects, data confirm that two-stage surgeries, transfers of 
patients from remote areas to urban centers, as well as service 
breaks in critical situations, were avoided. Improvements 
in medical care and diagnostic delay were also mentioned. 
Telepathology also helped curtail pathologist travel to several 
locations, a phenomenon which has resulted in clinical time 
gains.
Our evaluation showed that several teams used the technology 
for applications that were not initially planned, including 
for emergency biopsies, macroscopies, routine histologies, 
immuhistochemistry, cytology, education, and even 
teleautopsy. According to surgeons, telepathology could also 
be relevant for other clinical activities and other specialties 
(eg, endoscopy, gynecology, and orthopedics).
“(...) In endoscopy, we have never used it, while there are 
certain polyps that would benefit from being analyzed on 
site by telepathology. These are pieces that become damaged 
during back and forth travel and so become difficult to 
analyze (...)” (R1) [all interview quotes have been translated 
from French to English].
Also, the use of technology has been influenced by a 
combination of factors, including the evolution of scientific 
evidence and changes in clinical protocols, which have had a 
significant impact on the scope of the project:
“(...) Surgeons’ requests have changed. The most important 
demands were for sentinel lymph nodes (for breast cancer). 
(...) Following certain knowledge advances and according to 
[new] protocol, a lymph node is not important if the tumor 
is smaller than one centimeter. This phenomenon has greatly 
Figure 2. Strategic Framework for a Useful and Used Evaluation.30
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reduced the demand for telepathology (...). A resulting 
decrease in activity in this regard has been in the order of 
27% (...)” (R2). 
Clinical, Professional, and Human Aspects
Interpersonal relationships have been central in the decision 
as to whether or not to use telepathology. Indeed, much of 
the activity has emerged through existing trust relationships 
involving surgeons/pathologists/technologists. These include 
people from the same organization, as well as from two or 
more different organizations.
In addition, thanks to the dynamic described above, new 
practices procedures were developed and negotiated 
locally between pathologists and surgeons from different 
organizations (requester and respondent) to facilitate work 
involving telepathology beyond existing clinical protocols. 
These alliances and partnerships have evolved over time and 
vary according to the context.
“(…) We [pathologist-ENT, and surgeon] have established 
standards and criteria that help everyone (surgeon/
pathologist/technologist). For example, it’s the surgeon who 
sets the tone in the operating-room (...)” (R3). 
Surprisingly, telepathology was found to be of little help 
when it comes to promoting the recruitment and retention 
of pathologists in remote areas. It has also been reported that 
pathologists increasingly want to practice as a team. This issue 
concerns the quality of the work environment. On the other 
hand, telepathology has enabled recruiting and retaining 
surgeons in certain locations. Some surgeons mentioned that 
they would not have joined the organization or would have 
left it without telepathology.
Additionally, team dynamics were important, and even 
decisive, for the use (or non-use) of telepathology in networked 
work contexts or more centralized (or concentrated) 
organization contexts. For example, in one of the most active 
locations of the project, new pathologists could be trained in 
the use of telepathology by local team members in favour of 
the approach.
“(...) All the pathologists in the location in question (...) use 
telepathology. This allows everyone to acquire experience 
in this regard; they can exchange information about the 
cases they come across via telepathology. They collaborate 
extensively, thus enhancing their expertise. Everyone can 
develop their expertise (...)” (R2). 
This example illustrates the extensive support of some 
clinicians who worked on the project and enabled the necessary 
collaboration initiatives and partnerships for the development 
of telepathology services. Indeed, it appears that the decision 
to use telepathology is not only based on organizational will. 
Because of their professional autonomy, pathologists and 
surgeons decide to use (or not to use) telepathology and 
do so, to a greater or lesser extent, regardless, or not, of the 
organizational decision.
Moreover, the dynamic collaboration of the “pathologist-
technologist-surgeon” trio has been highlighted as decisive in 
the success or failure of telepathology. The evolution of this 
trio and the transformation of roles and responsibilities were 
underlined in the context of virtual network. In this sense, the 
importance of technologists in the telepathology services chain 
has been highlighted. It has also been reported that the role of 
technologists (eg, nature and load of work, responsibilities) 
was not sufficiently taken into account at the beginning of the 
project. In fact, when it comes to telepathology, technologists 
are required to digitize glass slides, take certain samples, and 
carry out procedures usually reserved for pathologists. 
This situation was observed in several locations in remote 
areas that do not have pathologists. In such locations, 
technologists have become the “extension of the pathologist’s 
arm” in the operating room (OR), given that no pathologist is 
actually on hand. In these locations, technologists have come 
to work closely with the surgeon, who in the past worked with 
a pathologist physically present in or close to the OR. Thus, 
the use of telepathology has relied strongly on the skills of 
technologists. According to some interviewed clinicians, it is 
important to improve the expertise of technologists so that 
they can carry out activities requested by the remotely located 
pathologist. For the latter, this competence also creates trust 
within the pathologist/technologist/surgeon trio. 
This new working configuration where the technologist has 
a preponderant role raises other professional (eg, reserved 
acts), economic (eg, expertise recognition and remuneration), 
and legal (eg, responsibility) questions and issues. For 
example, we observed that in one of the participating rural 
hospitals without onsite pathologist, a technologist found 
herself working as a “Laboratory Head.” With the use of 
telepathology, she carried out activities that were usually 
reserved for the pathologist. This technologist had a crucial 
role when it came to maintaining a certain level of surgical 
activity in this hospital.
This last point raises the issue of the recognition of a “new” 
status for technologists working in remote hospitals that do 
not have pathologists but that do offer surgical services. As 
such, the question of training and accreditation has been 
highlighted. As part of this project, the positive dynamic in 
some environments has led some pathologists to (informally) 
train technologists to use telepathology. Technologists have 
seen their work evolve and have to some extent become 
“pathologists’ assistants.” However, this status is not yet 
recognized in Quebec.
We have also observed the emergence of new modes of 
practice. One pathologist brings along digitized glass slides 
to read during his frequent travels between two provinces. 
Technology has also allowed pathologists who are unable to 
travel (eg, for family reasons or because of inclement weather) 
to work from home. 
The project has also faced certain difficulties in ensuring 
coverage of second-opinion or sub-specialized services, 
particularly in academic hospitals. Pathologists felt they were 
overwhelmed by the usual demands for services within their 
own organizations. Their fear of being overwhelmed by even 
more requests for services from other organizations partly 
explains their reluctance to use telepathology. However, 
other pathologists believe that telepathology could improve 
practice conditions in these centers, thus ensuring greater 
supraregional availability for these services. 
Moreover, we observed that most of the clinician and 
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manager “champions” who were able to implement and 
give legitimacy to the project are near retirement. Thus, 
the question of availability and training as regards the 
next generation of clinicians and managers is critical, and 
some interviewees pointed out the vulnerability of such 
an “individual-dependent” project. The risk of loss of 
“organizational memory” and “experiential wisdom” related 
to the project is significant. It was also reported in meetings 
and interviews that many professionals, including surgeons 
and dermatologists, were unaware of the project, or did not see 
its relevance or usefulness, when in fact they could have used 
it in some clinical situations. Promotion of the project and 
communication about it thus appear to have been insufficient.
Organizational Aspects
The project was designed to help improve the organization 
of services, not only for pathology but also for surgery. 
However, it was reported from various data sources that the 
link between telepathology and the organization of IUHN-
LU pathology and surgery services was unclear. The role of 
pathology, telepathology, and even telehealth on a broader 
scale in service organization plans and strategic orientations 
was murkier still.
The project was also highly dependent on changes in medical 
staff, especially the extensive mobility of pathologists in 
regional and sub-specialized hospitals. This mobility has 
impacted the supply and organization of services, especially 
since the critical mass of clinicians in the various settings was 
very low. This situation has created significant differences in 
the ability of hospitals to plan and provide in-house services or 
respond to requests from other organizations. Staff movement 
has been observed when it comes to telepathology itself, 
where it has contributed to a trend toward concentration of 
pathologists in a “regional hub.” This mobility has resulted in 
readjustments and changes in existing alliances, agreements, 
and collaborations among certain organizations.
“(...) Telepathology was an encouraging and catalytic element 
in my leaving the (...) [former organization]. For me, by 
joining (...) [a new organization], there was the possibility 
of covering all the regions through this regional hub where 
telepathology would have a role to play (...)” (R2). 
At the same time, organizations in the regions have expressed 
fears of losing their physicians following the implementation 
of telepathology and that pathologist positions would likely 
be transferred to regional centers where services could 
be provided via telepathology. The fact that at least two 
organizations which were using telepathology indeed lost 
their pathologist added credibility to this fear, regardless of 
the real reason of their departure. Organizations have thus 
expressed the need to be better informed on the management 
of pathologist positions in light of telepathology. This point 
was not actually taken into account when the project was 
implemented.
At another level, issues have been raised in relation to requests 
for services. For example, the question of OR management 
has been reported in documents, meetings and interviews. A 
frozen section session via telepathology may take more time 
than a session with the pathologist onsite (eg, to digitize glass 
slides, different communication mode). According to current 
performance and efficiency criteria, this situation may not 
allow for optimal OR management, either for the organization 
or for the surgeons whose remuneration does not take this 
element into account. This situation partly explains the 
fact that hospitals continue to use “itinerant” pathologists 
for frozen section sessions scheduled for a particular day 
of the week. However, this performance criterion has been 
deplored by other clinicians and managers. The latter point 
out that even if a frozen section session lasts one hour, this 
procedure is always more efficient than transferring the 
patient or performing a second surgery (eg, a surgeon may 
first operate on a patient to obtain a specimen. He sends it to 
the pathologist for analysis. The answer may take several days 
or weeks. The patient will then be operated a second time 
when the analyses are available.). Furthermore, the decision 
of discontinuing the use of telepathology for frozen sections 
should not be taken before solutions to improve the efficiency 
have been investigated. However, no such improvement 
procedure has been planned with the implementation. 
It was also found that organizing collaborative ventures 
that involved requesting and respondent locations varied 
according to the expertise, interests, and needs of the various 
organizations. The main point here is that the diversity of local 
contexts has led teams and organizations to work differently.
Governance and Strategic Aspects
The evaluation highlighted several elements that go far 
beyond the project under review. As for telehealth in general in 
Quebec, the planning and macro-management of the project 
were centralized and mostly “techno-centered,” in particular 
concerning the MHSS and some regional boards. Some 
clinicians explained their refusal to use telepathology given 
this “top down” approach where they were not consulted, nor 
sufficiently integrated into the project:
“(…) Physicians refused telepathology because it was 
imposed from the top [the Ministry and the organization] 
and they were not consulted beforehand. It should not be 
forgotten that doctors have autonomy with respect to their 
practice (...)” (R4).
Furthermore, the nature and definition of the roles, 
responsibilities, type and degree of involvement, and 
influences of the various participant organizations were 
unclear. For example, the supraregional responsibility of the 
academic hospital of reference was not clear to all the players, 
in particular concerning how it should fulfill its “safety net” 
role in order to ensure coverage for subspecialty services in 
remote areas.
In this case, the nature of incentives and conditions for 
service coverage were unclear for all organizations. Based 
on our information, no real procedure has been put in place 
to prioritize cases to be analyzed among organizations and 
their pathologists. In fact, service priorities are still primarily 
oriented toward in-house cases, where the pathologist works, 
instead of more urgent cases in another hospital. This last 
point puts into question the true nature of the contracts 
between organizations participating in the network, and 
therefore the obligation to comply with them.
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On another level, there was a consensus that the approach of 
those providing funding was relatively narrow with respect 
to project operation and technology use. The administrative 
constraints inherent to the performance indicators required 
for payment by sponsors were regularly brought up. The 
project team considered these indicators to be poorly adapted 
to local realities and opportunities and felt that they did not 
take the unique nature of each context into account. This 
situation has created difficulties for teams that have tried to 
adapt and align technology to their context, as well as to the 
evolution of their local needs and expertise. Managers and 
clinicians reported that a more open approach to the use of 
telepathology would have favored a more successful adoption 
and use of available technology:
“(...) The calculation is biased; the information received is 
used for calculation. These are real applications, but there are 
a lot of applications, such as support to macroscopic, that are 
not counted and don’t appear anywhere in the statistics. And 
when you look at the official figures, it gives the impression 
that it’s stabilized or that it doesn’t progress (...)” (R5).
In addition, many questions related to service contracts (eg, 
interoperability and archiving) have been raised. Managers 
and clinicians strongly agreed on the importance of setting 
up a national registry for the management, storage, and 
archiving of virtual slides. This national registry would lead 
to harmonize practices and better coordinate and integrate 
services.
In the same vein, it was also reported that a catalog of 
telepathology services should be developed to enable 
organizations to learn about all the services available. 
Managers and clinicians also found it essential to identify the 
various possible interconnections between this project and 
other provincial digital health initiatives, notably the “Quebec 
Health Record,” whose objective is to facilitate the collection, 
conservation, and consultation of patient-related medico-
administrative  information.
Technological Aspects
The speed of the high performance digitizer would not allow 
for more than one slide to be scanned every three minutes, 
which could slow pathologists’ ability to respond to requests 
made through telepathology. The digitising speed is however 
largely dependent on whether slides are being scanned at 20x 
or 40x and some pathologists prefer the highest power despite 
the additional time required. According to our observations 
and through our discussions and meetings with clinicians and 
project teams, serious questions were also raised regarding file 
size, speed of transmission, and archive locations. In addition, 
it was pointed out the need to have dynamic and sufficiently 
flexible systems to be able to take account the evolution of 
clinical and organizational needs.
Another major barrier highlighted was that the technological 
systems of the different organizations and those used by 
clinicians in their homes are not interoperable:
“(...) For example, when it comes to hospital (Y) and the other 
hospitals in the region, each has its own operating system 
for pathology. They are not able to communicate with each 
other at all. (...) We also have a pathologist from hospital (X) 
who helps us by working from home, but she cannot connect 
because she doesn’t have the same system (…)” (R4). 
Legal Aspects
The project’s clinical director raised a number of forensic 
issues concerning the use of telepathology. He has asserted 
that without the clarification of certain issues, the adoption 
and use of telepathology could be difficult.
In Quebec, the legislator requires the creation of a record both 
by the service requester and the service provider. This is also 
the position of the Canadian Medical Protective Association 
(CMPA). However, this requirement differs greatly from 
the current nature of the practice where pathologists 
receive e-mail requests. In this case, the receiving pathology 
department proceeds only with the creation of a request in 
the computer system, but does not create or open a record. In 
addition, the Act respecting health services and social services 
(ARHSS-2005) and the College of Physicians of Quebec 
require that two organizations that collaborate and use 
telehealth must sign an agreement. This situation is also new 
in pathology because traditionally pathologists who receive 
requests for consultation by regular mail do not require that 
an agreement is signed between the organizations involved.
In addition, the CMPA recommends that all images 
examined in telepathology be stored in accordance with 
current conservation schedules. For organizations, this 
recommendation would imply to have substantial space to 
store these images. The Clinical Director also questioned the 
necessity and relevance of conserving all the images produced 
by telepathology. However, it pointed out that virtual images 
likely to be the subject of litigation could be fully preserved.
Economic and Financing Aspects
It was out of the scope of the present evaluation to quantify 
the systemic added value of telepathology. However, we have 
identified different elements that seem to be necessary for a 
future medico-economic evaluation of this project, such as 
situations where patient transfers and two-stage surgeries 
have been avoided. In addition, cases where the technology 
has been used for services that were not planned initially (eg, 
teleautopsy) appear to have added value. However, the absence 
of monitoring to report these activities poses a challenge to 
conduct such evaluation.
The performance criteria and real gains for the requesting 
organization are unclear. Indeed, it is the responding 
organization that accounts activity, and therefore receives 
the funding associated with it. This situation could lead 
some organizations to refuse to use pathologists’ services via 
telepathology. In addition, it was stressed the importance of 
looking at the impact on the cost of patient management for 
the organizations involved.
“(...) It’s nice to not transfer the patient, but then we are stuck 
with him in our hospital (...) [to keep a patient involves costs 
for the organization] (...)” (R6).
On this point, it was also observed that some participating 
organizations wanted to offer telepathology services to 
increase their volume of activity, which would ultimately 
allow them to have other pathologist positions and increased 
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budget. Thus, the redistribution of savings achieved through 
telepathology between organizations poses several challenges 
(eg, nature of incentives, performance criteria for the 
requesting and the responding sites).
With respect to remuneration, it was found that establishing 
a telepathology network should require reviewing current 
payment modes, both for physicians (pathologists and 
surgeons) and technologists (valuation of activity). Indeed, 
telepathology implies other ways of functioning, such as 
teleworking for some pathologists. For surgeons, due to 
technological (eg, to digitize glass slide) and cognitive reasons 
that affect communication, telepathology takes somewhat 
longer time than when the pathologist is physically present in 
the OR (for its part, the Perron et al,18 study reported that the 
average time difference is not great, but still superior). This is 
particularly true when slides are being scanned at 40x whereas 
the additional time required is much less when slides are 
scanned at 20x. This situation implies a somewhat longer use 
of the OR, which raises questions of financial compensation 
for overtime, but also questions of OR management for the 
organization with the economic impact that it implies.
Finally, according to interviews, meetings and documents, 
limited funding does not consider the need to finance new 
equipment and new service modalities that are necessary 
for the sustainability and scaling-up of this network. This 
raises once again the question of the availability of recurrent 
funding. This element does not appear to have been taken 
into account at the emergence of the project, as it was 
initiated in response to an opportunity to fund telehealth 
projects from a federal funding organization (CHI). The fact 
that the project’s funding was of a limited and non-recurring 
duration, in addition to being mainly technology-oriented 
and not service-oriented, raises concerns for the follow-up 
of the project. Therefore, if it stops, the network would be 
threatened, at least in its present form.
Discussion
The project evaluated is unique by its nature, objectives 
and expectations. Because of its complex, innovative 
and structuring character, this project has contributed to 
addressing the concerns that are not normally addressed in 
initiatives that aim to provide efficient, effective, continuous 
and quality telehealth and health services for populations.
Telehealth involves major adjustments of organizational, 
professional, clinical and technological issues to be processed 
so to provide adequate services within an integrated and 
coordinated health system. Diverse and varied dimensions 
make technology - as a technical object - “secondary” in 
the midst of a complex health ecosystem, with often blurred 
contours. Thus, healthcare organizations are one of the most 
complex forms of social systems.39,40 In addition, the health 
system is a type of “professional bureaucracy” characterized 
by great decentralization and professional autonomy.41,42 New 
technology is thus introduced into social, organizational, 
and cultural environments with their individual histories 
and routines. For technology to be properly integrated, these 
systems must reorganize and restructure to discover a new 
equilibrium that would allow them to continue to evolve over 
time. Telehealth is a striking example of this phenomenon 
because it directly affects the provision of health services, 
which are at the core of the health system.
A Complex and Structuring Project
The project has attempted to network 22 locations, each with 
its own specific characteristics and dynamics: geographical 
(rural vs. urban), organizational, administrative, professional, 
and technological. This situation creates challenges of 
considerable magnitude when it comes to harmonizing and 
aligning various systems and processes, especially in an 
integrated service network vision.
This project shows also that the practice of pathology is 
inseparable from the practices of other clinicians, especially 
surgeons. Thus, a transformation of clinical practices and 
organization of services are required in order to be part of 
a comprehensive vision of the health system, where the 
alignment between specialties, modes of practice, and 
professional and organizational cultures, without forgetting 
local and regional contexts, is central to harmonizing and 
integrating services using technology as a lever. Harmonizing 
the strategic plans of participating organizations with MHSS 
strategies, policies, and priorities is also required, a further 
response to the “vagaries” of political contexts and government 
changes. For example, as we finalized the evaluation, Quebec 
underwent a major health system centralization reform that 
has disrupted the telepathology network and participant 
organizations. Indeed, with this reform, there was another 
project for the centralization of medical biology laboratories, 
which certain telepathology stakeholders were not aware of, 
although this project included the closure of a number of 
laboratories. This is the typical example of the disconnection 
and not alignment between different priorities, strategies and 
levels of governance.
This project cannot moreover be separated from its spatial 
and temporal context. Indeed, the project has evolved in light 
of new knowledge acquired on the ground and from other 
international experiences along the way, and it has been 
affected by regulatory and technological factors. As such, the 
project requires capacities, means, and leeway for action and 
reaction to deal with unpredictable events and developments 
at the clinical, organizational, political, and technological 
levels.
On the other hand, the project is also characterized by 
negotiations and exchanges involving a variety of actors 
and stakeholders who may have divergent visions and 
objectives and who maintain their autonomy and flexibility 
in an environment where all the actors remain ultimately 
interdependent.
Project Strengths
Clinical, Organizational and Technological Leadership
Undoubtedly, the strength of this project lies in its strong 
leadership at various levels (clinical, organizational, and 
technological). Indeed, responsibility for the project has 
remained in the hands of a team with extensive experience in 
the field and a history of close collaboration with the players 
involved. This helped establish a climate of mutual trust, 
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making it possible to address the various issues related to 
the progress and direction of the project in a serene climate, 
despite the many challenges and issues to be overcome over 
the course of the project. 
One of the noteworthy elements to highlight is the 
fundamental role of the clinical dimension at all levels and 
stages of the project. Indeed, strong clinical leadership helped 
overcome many of the challenges encountered during the 
project, notably those stemming from the initial vision as 
driven by the funders, a vision that was relatively rigid and 
mainly focused on specific uses of technology. The actors in 
the field have rethought and redefined this vision to anchor it 
in a clinical and organizational approach, going beyond the 
simple implementation of technology.
Moreover, strong clinical and organizational leadership 
has fostered a favorable dynamic with respect to the use of 
technology. On the other hand, we also found that this same 
leadership could be mobilized against the project itself. In 
fact, some clinicians were responsible for the refusal of certain 
organizations to use telepathology.
Collaboration and Innovation
Furthermore, the project created dynamics of collaboration 
and mutual assistance between clinicians and organizations. 
As a result, we have seen the construction of clinical platforms 
(refers to a model of clinical collaboration) adapted to local 
realities and organizational needs. This flexibility and 
dynamism in the field have led to the emergence of other 
uses for the technology. This was in part possible because the 
project favored a strategy capitalizing on local and regional 
collaborations and dynamics where the academic hospital 
acted as a “safety net” and not as the main distributor of 
services as is often the case for telepathology services. 
The bottom-up expertise was validated and recognized, 
thanks to a vitality of local teams, which can be considered as 
innovation laboratories that integrate clinical, organizational, 
and technical dimensions. Local teams were able to innovate 
and experiment using an exploratory approach more oriented 
toward their needs, going beyond what was initially planned 
in the project (eg, use of technology to do teleautopsy or 
teleformation). This process has made it possible to develop 
other ways to work and collaborate, using technology. 
Consequently, new roles and responsibilities have been 
negotiated locally to capitalize on the potential provided 
by telepathology. Such local dynamism can be seen as one 
of the conditions for project success. However, given all 
these local innovations, it is very difficult to implement and 
operationalize a single service model for all participating 
locations.
Challenges and Conditions for Sustainability
Challenges Inherent to the Organizational Transformations
Telepathology, and digital pathology, is accompanied by 
changes in structures, the organization of services, and clinical 
processes. It calls into question pre-existing organizational 
and professional cultures. In fact, it brings with it other 
forms of communication, which involve a reconfiguration 
of relations between clinicians, technologists, managers, and 
indirectly, patients, as well as between all these actors and the 
organization itself. 
Telepathology, at least in the Quebec context, requires 
technologists to develop significant expertise that allows 
them to become a central link in the proper functioning of 
the telepathology context in locations where no pathologists 
are on hand. This new situation raises issues regarding task 
delegation (eg, activities normally reserved for pathologists), 
and therefore their eventual validation. Technologists now 
perform what is called a “critical function,” which involves an 
interruption, even a paralysis, of the organization’s workflow if 
not performed.42,43 This said, the sustainability of telepathology 
is partly dependent on whether the organizations and other 
professional actors are able to accept, recognize, and formalize 
this new role of technologists.
On the other hand, telepathology involves a repositioning of 
relations and interactions between the actors themselves (eg, 
pathologists, technologists and surgeons), as well as between 
actors and the organization (eg, pathologists and their 
organizations). The novelty here is that the use of technology 
forces organizations to go beyond their physical dimension 
to integrate a wider environment, thus forming a sort of 
network-organization which is more structured around 
information flows and more and more “virtual teams.”
Nevertheless, the viability of these new networks depends 
on the nature and clarity of the cooperation routines that 
will be set up among the various actors (professional and 
organizational) concerned. Indeed, the question of confidence 
in change seemed decisive for such a restructuring to be 
possible and sustainable. In this instance, negotiation, in the 
logic of change management, takes on a central role in order 
to build a new configuration of relationships and interactions, 
which in turn leads actors collectively to learn, innovate and 
adopt new modes of practice, communication and work.43 
It is also important for organizations to develop a learning 
culture and become sufficiently flexible so as to benefit from 
the experience on the ground. 
Technology as “Use”
Telepathology also has an interactive character, which means 
that the professionals concerned, through their use of the 
technology, participate in its definition (or redefinition) by 
accepting it in its initial form, transforming and adapting 
it to their contexts and needs, or simply rejecting it.44 
Moreover, this innovative mode of practice is introduced in 
an environment where it confronts existing modes and habits 
of practice and organization. As such, we are left with socio-
technical systems where the technology interacts with a socio-
cultural environment, in particular the organization.45,46 Thus, 
it should be kept in mind that the technology could be subject 
to change due to its association and confrontation with other 
ideas and realities specific to each organizational and practice 
context.47 Recipients can design and use the technology in 
a different way than originally intended because each can 
interact with innovation in a way that differs from others, 
even if they belong to the same profession.47,48 In other words, 
it is use that gives value to the technology.49-51
In this project, the emergence of new local clinical platforms 
Alami et al
International Journal of Health Policy and Management, 2018, 7(5), 421–432430
was an adapted response to organizational and regional needs 
and realities, which may differ according to context and 
influenced by systemic issues. It was also a way for local teams 
to reach the objectives of covering the services expected by 
the MHSS. These local clinical platforms have enabled the 
emergence and consolidation of an inter-organizational and 
inter-regional dynamic that can be seen as a foundation for 
the development of an integrated, functional, and efficient 
national telepathology network.
The Challenge of Scale-up and Sustainability
The biggest challenge for the EQTN is to transition to the 
required scale and become sustainable. The first consideration 
remains the concrete support of decision-making authorities 
with a telehealth and health system vision and strategy, which 
is not entirely the case because of the lack of a global telehealth 
strategy in Quebec. This support should be materialized, 
in the short term, through the training and availability of 
innovation-sensitive human resources and to be galvanized 
by the clinical and organizational leadership required to 
enable an understanding of the complexity of health system 
transformations in the light of telehealth. This condition is 
essential in making available the support required for the 
rapid development of applications and uses of technology.
The prospect of sustainability also implies that several 
elements have to be deepened and many constraints 
overcome. This includes the need to find a new balance in the 
services provision model, which is conditioned by the extent 
to which stakeholders in the health system are able to agree on 
new dynamics in the production and delivery of services. This 
said, the standard top-down approaches limit creativity and 
the latitude circles needed to innovate and to uncover new 
practices.
Other issues with respect to ensuring EQTN sustainability 
were raised during this evaluation. First, it is important to 
consider the conditions for taking into account local needs 
and the local context on a broader scale. Institutionalization 
should not reduce the field’s capacity to adjust and adapt. 
Second, a central factor for EQTN sustainability remains the 
availability of recurrent funding. Indeed, one of the problems 
regularly encountered in telehealth projects is that they are 
initiated with provisional funds, where sustainability is not 
taken into account. In other words, the project funding 
will eventually become an end in itself for the initiators 
and not a means for improving the provision of services.52 
Funding strategies should foster longer-term approaches 
with sufficient flexibility to innovate (eg, avoid budgets 
aligned with so-called closed indicators). Computerization in 
health involves complex and slow transformations that take 
place over the long term, an approach that current funding 
models generally do not enable.52 Finally, the conditions 
of practice and remuneration of pathologists, surgeons, 
and technologists whose practices and responsibilities are 
impacted by telepathology must be better defined.
Conclusion
This work, which evaluated a telepathology network’s 
emergence, implementation and operation, helps to inform 
decision-makers on the importance of taking into account the 
complexity stemming from changes in models of production, 
delivery, and organization of health services with telehealth. 
The implementation of integrated telehealth networks requires 
a clear understanding of the professional, organizational, 
and political dynamics and synergies that exist between 
all stakeholders (individual and organizational) involved. 
Having a systemic vision that takes into consideration the 
complexity of health systems is also crucial. Future research-
evaluation must therefore be more sensitive to the complexity 
associated with the emergence of telehealth networks and no 
longer reduce them to solely technological considerations. 
Developmental-accompanying evaluation should be recognized 
as a lever to improve understanding of how these networks 
evolve in the dynamic, ever-changing environments that 
health systems represent and, ultimately, contributing to 
decision-making process.
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